Clinical consequences of resistance to ALK inhibitors in non-small cell lung cancer Article

Pinto, Joseph A, Raez, Luis E, Domingo, Gelenis. (2020). Clinical consequences of resistance to ALK inhibitors in non-small cell lung cancer . EXPERT REVIEW OF RESPIRATORY MEDICINE, 14(4), 385-390. 10.1080/17476348.2020.1721285

International Collaboration

cited authors

  • Pinto, Joseph A; Raez, Luis E; Domingo, Gelenis

sustainable development goals

authors

publication date

  • April 2, 2020

published in

keywords

  • ALECTINIB
  • ALK
  • BIOLOGY
  • CERITINIB
  • CHEMOTHERAPY
  • CRIZOTINIB RESISTANCE
  • Life Sciences & Biomedicine
  • MECHANISMS
  • METASTATIC SPREAD
  • MULTICENTER
  • Non-small cell lung cancer
  • OPEN-LABEL
  • Respiratory System
  • Science & Technology
  • THERAPY
  • tyrosine-kinase inhibitors

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 385

end page

  • 390

volume

  • 14

issue

  • 4